Literature DB >> 18218820

Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects.

Zongjin Li1, Yoriyasu Suzuki, Mei Huang, Feng Cao, Xiaoyan Xie, Andrew J Connolly, Phillip C Yang, Joseph C Wu.   

Abstract

Human embryonic stem (hES) cells are pluripotent stem cells capable of self-renewal and differentiation into virtually all cell types. Thus, they hold tremendous potential as cell sources for regenerative therapies. The concurrent development of accurate, sensitive, and noninvasive technologies capable of monitoring hES cells engraftment in vivo can greatly expedite basic research prior to future clinical translation. In this study, hES cells were stably transduced with a lentiviral vector carrying a novel double-fusion reporter gene that consists of firefly luciferase and enhanced green fluorescence protein. Reporter gene expression had no adverse effects on cell viability, proliferation, or differentiation to endothelial cells (human embryonic stem cell-derived endothelial cells [hESC-ECs]). To compare the two popular imaging modalities, hES cells and hESC-ECs were then colabeled with superparamagnetic iron oxide particles before transplantation into murine hind limbs. Longitudinal magnetic resonance (MR) imaging showed persistent MR signals in both cell populations that lasted up to 4 weeks. By contrast, bioluminescence imaging indicated divergent signal patterns for hES cells and hESC-ECs. In particular, hESC-ECs showed significant bioluminescence signals at day 2, which decreased progressively over the following 4 weeks, whereas bioluminescence signals from undifferentiated hES cells increased dramatically during the same period. Post-mortem histology and immunohistochemistry confirmed teratoma formation after injection of undifferentiated hES cells but not hESC-ECs. From these data taken together, we concluded that reporter gene is a better marker for monitoring cell viability, whereas iron particle labeling is a better marker for high-resolution detection of cell location by MR. Furthermore, transplantation of predifferentiated rather than undifferentiated hES cells would be more suited for avoiding teratoma formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218820      PMCID: PMC3638035          DOI: 10.1634/stemcells.2007-0843

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  39 in total

1.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors.

Authors:  J Yamashita; H Itoh; M Hirashima; M Ogawa; S Nishikawa; T Yurugi; M Naito; K Nakao; S Nishikawa
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

2.  Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology.

Authors:  Hans Reinecke; Charles E Murry
Journal:  J Mol Cell Cardiol       Date:  2002-03       Impact factor: 5.000

3.  Endothelial progenitor cells.

Authors:  Anthony Rosenzweig
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

Review 4.  Bone-marrow stem cells as a source for cell therapy.

Authors:  Ray C-J Chiu
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

5.  Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI.

Authors:  Raphael Guzman; Nobuko Uchida; Tonya M Bliss; Dongping He; Karen K Christopherson; David Stellwagen; Alexandra Capela; Joan Greve; Robert C Malenka; Michael E Moseley; Theo D Palmer; Gary K Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-06       Impact factor: 11.205

6.  Endothelial cells derived from human embryonic stem cells.

Authors:  Shulamit Levenberg; Justin S Golub; Michal Amit; Joseph Itskovitz-Eldor; Robert Langer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

7.  Neural progenitors from human embryonic stem cells.

Authors:  B E Reubinoff; P Itsykson; T Turetsky; M F Pera; E Reinhartz; A Itzik; T Ben-Hur
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

8.  Feeder-free growth of undifferentiated human embryonic stem cells.

Authors:  C Xu; M S Inokuma; J Denham; K Golds; P Kundu; J D Gold; M K Carpenter
Journal:  Nat Biotechnol       Date:  2001-10       Impact factor: 54.908

9.  Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells.

Authors:  Chunhui Xu; Shailaja Police; Namitha Rao; Melissa K Carpenter
Journal:  Circ Res       Date:  2002-09-20       Impact factor: 17.367

10.  In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction.

Authors:  Dara L Kraitchman; Alan W Heldman; Ergin Atalar; Luciano C Amado; Bradley J Martin; Mark F Pittenger; Joshua M Hare; Jeff W M Bulte
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

View more
  86 in total

Review 1.  Advances in cardiovascular molecular imaging for tracking stem cell therapy.

Authors:  Katherine J Ransohoff; Joseph C Wu
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

2.  Magnetic resonance imaging probes for labeling of chondrocyte cells.

Authors:  Gang Liu; Chunchao Xia; Zhiyong Wang; Fei Lv; Fabao Gao; Qiyong Gong; Bin Song; Hua Ai; Zhongwei Gu
Journal:  J Mater Sci Mater Med       Date:  2011-01-30       Impact factor: 3.896

Review 3.  A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.

Authors:  Anna J Studwell; Darrell N Kotton
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

Review 4.  In vivo imaging and monitoring of transplanted stem cells: clinical applications.

Authors:  Martin Rodriguez-Porcel
Journal:  Curr Cardiol Rep       Date:  2010-01       Impact factor: 2.931

5.  In vivo magnetic resonance imaging of injected endothelial progenitor cells after myocardial infarction in rats.

Authors:  Yuyu Yao; Yefei Li; Genshan Ma; Naifeng Liu; Shenghong Ju; Jiyang Jin; Zhong Chen; Chengxing Shen; Gaojun Teng
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

6.  Gene-modified adult stem cells regenerate vertebral bone defect in a rat model.

Authors:  Dmitriy Sheyn; Ilan Kallai; Wafa Tawackoli; Doron Cohn Yakubovich; Anthony Oh; Susan Su; Xiaoyu Da; Amir Lavi; Nadav Kimelman-Bleich; Yoram Zilberman; Ning Li; Hyun Bae; Zulma Gazit; Gadi Pelled; Dan Gazit
Journal:  Mol Pharm       Date:  2011-09-13       Impact factor: 4.939

Review 7.  Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.

Authors:  Martin Rodriguez-Porcel; Marvin W Kronenberg; Timothy D Henry; Jay H Traverse; Carl J Pepine; Stephen G Ellis; James T Willerson; Lemuel A Moyé; Robert D Simari
Journal:  JACC Cardiovasc Imaging       Date:  2012-05

Review 8.  Generation of Human Pluripotent Stem Cell-derived Endothelial Cells and Their Therapeutic Utility.

Authors:  Shin-Jeong Lee; Kyung Hee Kim; Young-Sup Yoon
Journal:  Curr Cardiol Rep       Date:  2018-05-05       Impact factor: 2.931

Review 9.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

10.  Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart.

Authors:  Koen E A van der Bogt; Sonja Schrepfer; Jin Yu; Ahmad Y Sheikh; Grant Hoyt; Johannes A Govaert; Jeffrey B Velotta; Christopher H Contag; Robert C Robbins; Joseph C Wu
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.